Delivery Order SPE2DB22D2006-SPE2DB25FW4BB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,265.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-competitive delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a $5,066.24 delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, was competitively awarded without a set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,156.39 and is scheduled for completion by September 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,914.54 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used in the treatment of autoimmune conditions. The award was made on May 2, 2025, with an ultimate completion date of May 5, 2025, utilizing firm fixed-price pricing under a competitive, non-set-aside procurement. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,265.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive, non-set-aside delivery order. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,587.22 to AmerisourceBergen Drug Corp for the supply of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,502.00 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on April 29, 2025, is scheduled for ultimate completion by April 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,166.56 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competed delivery order under AmerisourceBergen's existing DLA contract vehicle. The place of performance is listed as the company's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,477.89 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating autoimmune conditions. This firm fixed price delivery order, awarded on May 14, 2025, with an ultimate completion date of May 15, 2025, was issued without a set-aside designation and represents a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4BBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,054.00 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-set-aside contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under a larger contract vehicle that provides DLA with pharmaceutical supply capabilities. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that consistently demonstrates capability to fulfill federal medical procurement requirements through competitive awards, serving critical federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 9/5/25 |